Novartis cardiovascular drugs
- Health
Novartis Acquires Anthos Therapeutics in $3.1B Deal to Bolster Stroke Prevention Drug
Novartis Expands Cardiovascular Portfolio with Anthos Therapeutics AcquisitionPharmaceutical giant Novartis is set to acquire U.S.-based biotech company Anthos Therapeutics from…
Read More »